- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 18, Pages 10716
Publisher
MDPI AG
Online
2022-09-15
DOI
10.3390/ijms231810716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1
- (2022) Xiao Sun et al. CELL DEATH AND DIFFERENTIATION
- Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach
- (2022) Abdulrahim R. Hakami Biology-Basel
- Multifaceted role of natural sources for COVID-19 pandemic as marine drugs
- (2022) Md. Mominur Rahman et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
- (2022) Yongsheng Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Importance of Nutraceuticals in COVID-19: What’s the Role of Resveratrol?
- (2022) Elisa Domi et al. MOLECULES
- Molecular mechanism underlying the TLR4 antagonistic and antiseptic activities of papiliocin, an insect innate immune response molecule
- (2022) Manigandan Krishnan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phytomedicines explored under in vitro and in silico studies against coronavirus: An opportunity to develop traditional medicines
- (2022) Yashika Gandhi et al. SOUTH AFRICAN JOURNAL OF BOTANY
- Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
- (2022) Mohammad Afsar et al. eLife
- Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine
- (2021) Sonia Jangra et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- TLR2-mediated innate immune priming boosts lung anti-viral immunity
- (2021) Jason Girkin et al. EUROPEAN RESPIRATORY JOURNAL
- Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets
- (2021) Muhammad Tahir Khan et al. INTERVIROLOGY
- RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2
- (2021) Avinash Mishra et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
- (2021) Mohamed M. Aboudounya et al. MEDIATORS OF INFLAMMATION
- TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
- (2021) Marina Luchner et al. Pharmaceutics
- Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
- (2021) Vicky Mody et al. Communications Biology
- Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature
- (2021) Giuseppe Fabio Parisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19
- (2021) Molly K. Roe et al. JOURNAL OF GENERAL VIROLOGY
- Role of Toll‐like receptors in the pathogenesis of COVID‐19
- (2021) Shaghayegh Khanmohammadi et al. JOURNAL OF MEDICAL VIROLOGY
- A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
- (2021) Francis K. Yoshimoto PROTEIN JOURNAL
- Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity
- (2021) Chu-Wen Yang et al. PeerJ
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
- (2021) Markus Hoffmann et al. EBioMedicine
- SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
- (2021) Neha Vithani et al. BIOPHYSICAL JOURNAL
- TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
- (2021) Dhriti Kaushik et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Coronavirus genomic nsp14‐ExoN, structure, role, mechanism, and potential application as a drug target
- (2021) Mohammed Tahir JOURNAL OF MEDICAL VIROLOGY
- The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
- (2021) Dounia Darif et al. MICROBIAL PATHOGENESIS
- Can nutraceuticals assist treatment and improve covid-19 symptoms?
- (2021) Alessio Alesci et al. NATURAL PRODUCT RESEARCH
- TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
- (2021) Min Zheng et al. NATURE IMMUNOLOGY
- Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP
- (2021) Mahamaya Biswal et al. NUCLEIC ACIDS RESEARCH
- COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?
- (2021) Vanessa Dela Justina et al. VASCULAR PHARMACOLOGY
- Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury
- (2021) Nicolas Melin et al. Cell Death & Disease
- The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA
- (2021) Jasmine Cubuk et al. Nature Communications
- Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
- (2021) Damir Bojadzic et al. ACS Infectious Diseases
- Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
- (2021) Ali A. Rabaan et al. Vaccines
- Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
- (2021) Jennifer C. Milligan et al. BIOCHEMICAL JOURNAL
- Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease
- (2021) Chew Theng Lim et al. BIOCHEMICAL JOURNAL
- Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
- (2021) Shetty Ravi Dyavar et al. BIOMEDICINE & PHARMACOTHERAPY
- TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4 + T Cells
- (2021) Siqin Duan et al. JOURNAL OF VIROLOGY
- Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses
- (2021) Yujuan Chen et al. Journal of Zhejiang University-SCIENCE B
- Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions
- (2021) Kundlik Gadhave et al. MICROBIAL PATHOGENESIS
- SARS-CoV-2 takes its Toll
- (2021) Alan Sariol et al. NATURE IMMUNOLOGY
- SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction
- (2021) Marc Lavigne et al. NUCLEIC ACIDS RESEARCH
- The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
- (2021) Devi SenGupta et al. Science Translational Medicine
- Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients
- (2021) Maria Clara Saad Menezes et al. Scientific Reports
- Crucial mutation in the exoribonuclease domain of nsp14 of PEDV leads to high genetic instability during viral replication
- (2021) Xiaoyu Niu et al. Cell and Bioscience
- Structure and Function of N-Terminal Zinc Finger Domain of SARS-CoV-2 NSP2
- (2021) Jun Ma et al. VIROLOGICA SINICA
- SARS-CoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8
- (2021) Valentina Salvi et al. JCI Insight
- TLR3 and TLR7 RNA Sensor Activation during SARS-COV-2 Infection
- (2021) Daria Bortolotti et al. Microorganisms
- Modulation of Toll-like receptor 1 intracellular domain structure and activity by Zn2+ ions
- (2021) Vladislav A. Lushpa et al. Communications Biology
- The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target
- (2021) Gergely Rona et al. CELL DEATH AND DIFFERENTIATION
- TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
- (2021) F. Linzee Mabrey et al. Innate Immunity
- An insight into SARS-CoV-2 membrane protein interaction with spike, envelope, and nucleocapsid proteins
- (2021) Prateek Kumar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
- (2021) Moumita Manik et al. JOURNAL OF MEDICAL VIROLOGY
- Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
- (2021) Rittibet Yapasert et al. MOLECULES
- Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
- (2021) Xiaolei Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage
- (2021) Tiago J. Costa et al. VASCULAR PHARMACOLOGY
- Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections
- (2021) Marta Maria Gaglia Virology Journal
- Structural, energetic and lipophilic analysis of SARS-CoV-2 non-structural protein 9 (NSP9)
- (2021) Jéssica de O. Araújo et al. Scientific Reports
- SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway
- (2021) Shahanshah Khan et al. eLife
- The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
- (2021) Iqrar Ahmad et al. Topics in Current Chemistry
- Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19
- (2021) Tarlan Mamedov et al. Vaccines
- Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) Autocleavage Enzyme Critical for COVID-19 Pathogenesis
- (2021) Sreus A. G. Naidu et al. Journal of Dietary Supplements
- Processing of the SARS-CoV pp1a/ab nsp7-10 region
- (2020) Boris Krichel et al. BIOCHEMICAL JOURNAL
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis
- (2020) Silvia Angeletti et al. JOURNAL OF MEDICAL VIROLOGY
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Return of the Coronavirus: 2019-nCoV
- (2020) Lisa E. Gralinski et al. Viruses-Basel
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
- (2020) Sairaj Satarker et al. ARCHIVES OF MEDICAL RESEARCH
- Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19
- (2020) Tonino Bombardini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Toll-like Receptors and the Control of Immunity
- (2020) Katherine A. Fitzgerald et al. CELL
- Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
- (2020) Pan Luo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Peptide-like and small-molecule inhibitors against Covid-19
- (2020) Suyash Pant et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Structural and Simulation analysis of hot spot residues interactions of SARS-CoV 2 with Human ACE2 receptor
- (2020) Ganesh Kumar Veeramachaneni et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
- (2020) Abdo A. Elfiky JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
- (2020) Manoj Kumar Gupta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy
- (2020) Domenico Benvenuto et al. JOURNAL OF INFECTION
- Consider TLR5 for new therapeutic development against COVID‐19
- (2020) Chiranjib Chakraborty et al. JOURNAL OF MEDICAL VIROLOGY
- Genotype and phenotype of COVID-19: Their roles in pathogenesis
- (2020) Leila Mousavizadeh et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
- (2020) Mario Adán Moreno-Eutimio et al. MICROBES AND INFECTION
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence
- (2020) Soo Seok Hwang et al. SCIENCE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
- (2020) Yosra A. Helmy et al. Journal of Clinical Medicine
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study
- (2020) Muhammad Tahir Khan et al. ARCHIVES OF MICROBIOLOGY
- The cytokine storm of COVID-19: a spotlight on prevention and protection
- (2020) Lucie Pearce et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
- (2020) Julia Hippisley-Cox et al. HEART
- Presence of Genetic Variants Among Young Men With Severe COVID-19
- (2020) Caspar I. van der Made et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences
- (2020) Melika Lotfi et al. JOURNAL OF MEDICAL VIROLOGY
- Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
- (2020) Sebastiano Cicco et al. MEDIATORS OF INFLAMMATION
- Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
- (2020) Petra Krafcikova et al. Nature Communications
- Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9
- (2020) Dene R. Littler et al. iScience
- Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques
- (2020) Alexander Kwarteng et al. BIOMEDICINE & PHARMACOTHERAPY
- Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
- (2020) Athina Angelopoulou et al. ENVIRONMENTAL RESEARCH
- Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
- (2020) Stefano Federico et al. JOURNAL OF MEDICINAL CHEMISTRY
- A role for quercetin in coronavirus disease 2019 (COVID‐19)
- (2020) Giuseppe Derosa et al. PHYTOTHERAPY RESEARCH
- High-resolution structures of the SARS-CoV-2 2′-O-methyltransferase reveal strategies for structure-based inhibitor design
- (2020) Monica Rosas-Lemus et al. Science Signaling
- Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
- (2020) Sumanth Khadke et al. Virology Journal
- Regulation of RLR-Mediated Antiviral Responses of Human Dendritic Cells by mTOR
- (2020) Tünde Fekete et al. Frontiers in Immunology
- The Inflammasome in Times of COVID-19
- (2020) Juan Carlos de Rivero Vaccari et al. Frontiers in Immunology
- Curcumin (a constituent of turmeric): New treatment option against COVID‐19
- (2020) Fatemeh Babaei et al. Food Science & Nutrition
- Antiviral efficacy of orally delivered neoagarohexaose, a nonconventional TLR4 agonist, against norovirus infection in mice
- (2020) Minwoo Kim et al. BIOMATERIALS
- Therapeutic potential of TLR8 agonist GS‐9688 (selgantolimod) in chronic hepatitis B: re‐modelling of antiviral and regulatory mediators
- (2020) Oliver E. Amin et al. HEPATOLOGY
- Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
- (2020) Ziyad Tariq Muhseen et al. JOURNAL OF MOLECULAR LIQUIDS
- Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
- (2020) Jaeyong Lee et al. Nature Communications
- Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
- (2020) Pamela C. Proud et al. EBioMedicine
- Lawsonia inermis L. leaves aqueous extract as a natural antioxidant and antibacterial product
- (2019) Amin Pasandi Pour et al. NATURAL PRODUCT RESEARCH
- Membrane binding proteins of coronaviruses
- (2019) Entedar A J Alsaadi et al. Future Virology
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
- (2019) Ayman Mubarak et al. Journal of Immunology Research
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir
- (2019) Anne-France Georgel et al. ANTIVIRAL RESEARCH
- CD82 controls CpG-dependent TLR9 signaling
- (2019) Nida S. Khan et al. FASEB JOURNAL
- Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases
- (2019) Yelin Han et al. Frontiers in Microbiology
- Toll-like receptor-6 signaling prevents inflammation and impacts composition of the microbiota during inflammation-induced colorectal cancer
- (2019) Jee-Hyun Kim et al. Cancer Prevention Research
- TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection
- (2019) Marine de Marcken et al. Science Signaling
- The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases
- (2019) Pardis Mohammadi Pour et al. Frontiers in Pharmacology
- Evolutionary History of the Toll-Like Receptor Gene Family across Vertebrates
- (2019) Guangshuai Liu et al. Genome Biology and Evolution
- Innate immune responses through Toll-like receptor 3 require human-antigen-R-mediated Atp6v0d2 mRNA stabilization
- (2019) Mohd Izwan Bin Zainol et al. Scientific Reports
- Lactoferrin: major physiological functions and applications
- (2018) Liyuan Hao et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
- (2018) Kumar Vijay INTERNATIONAL IMMUNOPHARMACOLOGY
- Dimerization of Coronavirus nsp9 with Diverse Modes Enhances Its Nucleic Acid Binding Affinity
- (2018) Zhe Zeng et al. JOURNAL OF VIROLOGY
- Ulinastatin Protects Against LPS-Induced Acute Lung Injury by Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators
- (2018) Chao Cao et al. SHOCK
- Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin
- (2018) Bénédicte Vanwalscappel et al. VIROLOGY
- Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals
- (2018) Li Nie et al. Frontiers in Immunology
- Understanding early TLR signaling through the Myddosome
- (2018) Katherine R. Balka et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-like receptor 2 antagonists identified through virtual screening and experimental validation
- (2017) Prasannavenkatesh Durai et al. FEBS Journal
- Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma
- (2017) Moucheng Zhang et al. OncoTargets and Therapy
- Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
- (2017) Yuan Yuan et al. Nature Communications
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
- (2017) Hua Su et al. Frontiers in Immunology
- Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
- (2017) Ivan Zanoni et al. Frontiers in Immunology
- Understanding the dynamics of Toll-like Receptor 5 response to flagellin and its regulation by estradiol
- (2017) Ignacio Caballero et al. Scientific Reports
- The critical role of toll-like receptors — From microbial recognition to autoimmunity: A comprehensive review
- (2016) Maximiliano Javier Jiménez-Dalmaroni et al. AUTOIMMUNITY REVIEWS
- Advances in Antiviral Therapies Targeting Toll-like Receptors
- (2016) Masaud Shah et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Recent progress in the development of Toll-like receptor (TLR) antagonists
- (2016) Mahesh Chandra Patra et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA
- (2016) Zhikuan Zhang et al. IMMUNITY
- The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice
- (2016) Xingxu Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses
- (2016) Diego Forni et al. JOURNAL OF VIROLOGY
- The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
- (2016) Monica Molteni et al. MEDIATORS OF INFLAMMATION
- Toremifene interacts with and destabilizes the Ebola virus glycoprotein
- (2016) Yuguang Zhao et al. NATURE
- Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes
- (2016) Yu Wang et al. PHARMACOLOGY & THERAPEUTICS
- p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLprovia E3 ubiquitin ligase RCHY1
- (2016) Yue Ma-Lauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate recognition of microbial-derived signals in immunity and inflammation
- (2016) Yue Zhang et al. Science China-Life Sciences
- Antiviral activity of luteolin against Japanese encephalitis virus
- (2016) Wenchun Fan et al. VIRUS RESEARCH
- Type I interferons in viral control and immune regulation
- (2016) John R Teijaro Current Opinion in Virology
- Recent progress in the discovery of inhibitors targeting coronavirus proteases
- (2016) Haofeng Wang et al. VIROLOGICA SINICA
- Toll-like receptors: potential targets for lupus treatment
- (2015) Yan-wei Wu et al. ACTA PHARMACOLOGICA SINICA
- Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference
- (2015) Justin K. Taylor et al. JOURNAL OF VIROLOGY
- Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations
- (2015) Francesco Gentile et al. MOLECULES
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex
- (2015) Yuanyuan Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiotensin-Converting Enzyme Inhibition Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating the Balance Between Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 and Inhibiting Mitogen-Activated Protein Kinase Activation
- (2015) Yingchuan Li et al. SHOCK
- Coronavirus envelope (E) protein remains at the site of assembly
- (2015) Pavithra Venkatagopalan et al. VIROLOGY
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coronavirus NSP6 restricts autophagosome expansion
- (2014) Eleanor M Cottam et al. Autophagy
- CoronavirusNsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes
- (2014) Mickaël Bouvet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
- (2014) Vineet D. Menachery et al. VIRUS RESEARCH
- Correction: In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation
- (2014) Mickaël Bouvet et al. PLoS Pathogens
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Toll-Like Receptor–2/6 and Toll-Like Receptor–9 Agonists Suppress Viral Replication but Not Airway Hyperreactivity in Guinea Pigs
- (2013) Matthew G. Drake et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge
- (2013) Carmina Verdiá-Báguena et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Toll-Like Receptor 6 Plays an Important Role in Host Innate Resistance to Brucella abortus Infection in Mice
- (2013) Leonardo A. de Almeida et al. INFECTION AND IMMUNITY
- Toll-Like Receptors in Antiviral Innate Immunity
- (2013) Sandra N. Lester et al. JOURNAL OF MOLECULAR BIOLOGY
- Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2
- (2013) Y. Ge et al. JOURNAL OF VIROLOGY
- Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity
- (2013) Christopher C. Stobart et al. JOURNAL OF VIROLOGY
- Signaling Organelles of the Innate Immune System
- (2012) Jonathan C. Kagan CELL
- A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide
- (2012) Changhyun Roh International Journal of Nanomedicine
- Antiviral Properties of Glycyrrhizic Acid and its Semisynthetic Derivatives
- (2012) Raffaello Pompei et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Systematic identification of type I and type II interferon-induced antiviral factors
- (2012) S.-Y. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective Role of Toll-like Receptor 3-Induced Type I Interferon in Murine Coronavirus Infection of Macrophages
- (2012) Liudmila Mazaleuskaya et al. Viruses-Basel
- The Role of TLR2 in Infection and Immunity
- (2012) Laura Oliveira-Nascimento et al. Frontiers in Immunology
- Emodin inhibits current through SARS-associated coronavirus 3a protein
- (2011) Silvia Schwarz et al. ANTIVIRAL RESEARCH
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension
- (2011) Aartjan J.W. te Velthuis et al. NUCLEIC ACIDS RESEARCH
- Recent insights into the role of Toll-like receptors in viral infection
- (2010) M. Carty et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Intracellular Toll-like Receptors
- (2010) Amanda L. Blasius et al. IMMUNITY
- A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages
- (2010) Yu Zhou et al. IMMUNOLOGY
- The Hydrophobic Domain of Infectious Bronchitis Virus E Protein Alters the Host Secretory Pathway and Is Important for Release of Infectious Virus
- (2010) T. R. Ruch et al. JOURNAL OF VIROLOGY
- A Conserved Domain in the Coronavirus Membrane Protein Tail Is Important for Virus Assembly
- (2010) A. L. Arndt et al. JOURNAL OF VIROLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice
- (2010) Yuk-Fai Lau et al. VIROLOGY
- Interactions of SARS Coronavirus Nucleocapsid Protein with the host cell proteasome subunit p42
- (2010) Qin Wang et al. Virology Journal
- SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism
- (2010) Xiaolu Lu et al. VIRUS GENES
- Autocrine Interferon Priming in Macrophages but Not Dendritic Cells Results in Enhanced Cytokine and Chemokine Production after Coronavirus Infection
- (2010) H. Zhou et al. mBio
- The antiviral activity of toll-like receptor 7 and 7/8 agonists
- (2009) R.L. Miller et al. DRUG NEWS & PERSPECTIVES
- Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
- (2009) B. R. O'Keefe et al. JOURNAL OF VIROLOGY
- Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signaling
- (2009) C. T. Cornillez-Ty et al. JOURNAL OF VIROLOGY
- Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands
- (2009) Roman Barbalat et al. NATURE IMMUNOLOGY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
- (2009) Yuk-Fai Lau et al. VACCINE
- FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection
- (2009) William A Rose et al. Virology Journal
- Innate immunity to virus infection
- (2008) Osamu Takeuchi et al. IMMUNOLOGICAL REVIEWS
- Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells
- (2008) K. Narayanan et al. JOURNAL OF VIROLOGY
- Protective Effect of Toll-like Receptor 4 in Pulmonary Vaccinia Infection
- (2008) Martha A. Hutchens et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More